Cipla Therapeutics

Cipla Therapeutics is the specialty pharmaceutical division of Cipla, a global pharmaceutical leader, focused on the development and commercialization of complex therapies in the United States. The company primarily operates in the respiratory, central nervous system (CNS), and institutional care therapeutic areas. Its portfolio includes branded specialty products such as Zembrace SymTouch and Tosymra for the treatment of acute migraine, alongside a robust line of complex generic inhalation products like Albuterol Sulfate. By combining Cipla's extensive global R&D and manufacturing capabilities with a dedicated US commercial infrastructure, Cipla Therapeutics aims to improve patient access to high-quality, affordable specialty medicines. The company continues to expand its pipeline through internal development and strategic partnerships targeting unmet needs in chronic and acute care settings.